Alterations in exon 1 of c-myc and expression of p62(c-myc) in cervical squamous cell carcinoma

Journal of Clinical Pathology

Volumn 50, Issue 11, 1997, Pages 896-903

  O'Leary, J J ^a,d   Landers, R J ^b   Crowley, M ^c   Healy, I ^c   Kealy, W F ^c   Hogan, J ^c   Doyle, C T ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

C myc; Cervical cancer; Exon 1 alterations; Human papillomavirus

Indexed keywords

MESSENGER RNA; MONOCLONAL ANTIBODY; ONCOPROTEIN; PROTEIN P62; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE C MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; UTERINE CERVIX CARCINOMA; WART VIRUS;

EID: 0030733147     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.11.896     Document Type: Article

References (30)

1. Bishop JM. Viral oncogenes. Cell 1985;42:23-38.
2. Muller R, Slamon DJ, Tremblay J, Cline N, Verma IM. Differential expression of cellular oncogenes during pre and post-natal development of the mouse. Nature 1982;299: 640-4.
3. Lachman HM, Skoultchi AI. Expression of c-myc changes during differentiation of mouse erythroleukaemia cells. Nature 1984;310:592-4.
4. Goyette M, Petropoulos GJ, Shank PR, Fausto N. Expression of a cellular oncogene during liver regeneration. Science 1983;219:510-17.
5. Vastrik I, Makela TP, Koskinen PJ, Klefstrom J, Alitalo K. Myc protein: partners and antagonists. Crit Rev Oncol 1994;5:59-68.
6. Amati B, Land H. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr Opin Genet Dev 1994;4:102-8.
7. Sikora K, Evan G, Watson J. Oncogenes and germ cell tumours. Int J Androl 1987;10:57-67.
8. Ciclitria PJ, McCartney JC, Evan G. Expression of c-myc in non-malignant and pre-malignant gastro-intestinal disorders. J Pathol 1987;151:293-6.
9. Evan G, Harrington E, Fanidi A, Land H, Amati B, Bennett M. Integrated control of cell proliferation and cell death by the c-myc oncogene. Philos Trans R Soc Lond Biol Sci 1994; 345:269-75.
10. Einat M, Resnitzky D, Kimchi A. Close link between reduction of c-myc expression by interferon and Go/ G1 arrest. Nature 1985;313:597-600.
11. Hann SR, Thompson CB, Eisenmann RN. c-myc Oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature 1985;314:366-9.
12. Yokota J, Tsunetsugu-Yokota Y, Battifora H, Lefevie C, Cline MJ. Alterations of myc, myb and ras-Ha proto-oncogenes in cancers are frequent and show clinical correlation. Science 1986;231:261-5.
13. Kelly K, Siebenlist U. The regulation and expression of c-myc in normal and malignant cells. Annu Rev Immunol 1986;4:317-38.
14. Gariglio P, del Angel R, Herrera A, Bonilla M, Theoretical model for the post-transcriptional regulation of the human c-myc gene expression, involving double-stranded RNA processing. J Theor Biol 1987;125:83-92.
15. Rabbitts TH, Hamlyn PH, Baer R. Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma. Nature 1983;306:760-5.
16. Dalla-Favera R, Wong-Staal F, Gallo RC. One gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemia cells of the same patient. Nature 1982;299: 61-3.
17. Rabbitts TH, Forster A, Hamlyn, Baer R. Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma. Nature 1984;309:592-7.
18. Rabbitts PH, Forster A, Stison MA, Rabbitts TH. Truncation of exon 1 from the c-myc gene results in prolonged c-myc mRNA stability. EMBO J 1985;4:3727-33.
19. Riou G, Le MG, Le Doussal V, Barrois M, George M, Haie C. c-myc Proto-oncogene expression and prognosis in early carcinoma of the uterine cervix. Lancet 1987;ii:761-3.
20. Ocadiz R, Sauceda R, Salcedo M, Onega V, Rodriguez H, Gordillo C, et al. Occurrence of human papillomavirus type 16 and c-myc alterations in uterine cervix carcinoma. Arch Invest Med Mexico 1989;20:355-62.
21. Munzel P, Marx D, Kochel H, Scjauer A, Bock KW Genomic alterations of the c-myc protoncogene in relation to the overexpression of c-erbB2 and Ki-67 in human breast and cervix carcinoma. J Cancer Res Clin Oncol 1991; 117:603-7.
22. O'Leary JJ, Browne G, Landers RJ, Crowley M, Healy I, Bashir MS, et al. Non-isotopic detection of DNA in tissues. In: Levy ER, Herrington CS, eds. In-situ hybridisation. A practical approach series. Oxford: Oxford University Press, 1994:51-83.
23. Arends MJ, Donaldson YK, Duvall E, Wyllie AH, Bird CC. HPV in full thickness cervical biopsies: high prevalence in CIN 2 and CIN 3 detected by a sensitive PCR method. J Pathol 1991;165:301-9.
24. Van den Brule AJC, Snijders PJF, Gordijn RLJ, Bleker OP, Meijer CJLM, Walboomers JMM. General primer-mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas. Int J Cancer 1990;45:644-9.
25. Evan GI, Lewis GK, Ramsay G, Bishop JM. Isolation of monoclonal antibodies specific for the human c-myc proto-oncogene product. Mol Cell Biol 1985;5:3610-16.
26. Ocadiz R, Sauceda R, Cruz M, Graef AM, Gariglio P. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix. Cancer Res 1987;47:4173-7.
27. Huang SL, Liu ZQ, Zhang XN, Li MJ. Human papilloma virus, human cytomegalovirus and oncogene c-myc in cervical carcinoma and cervicitis. Chin Med J 1993;106:208-10.
28. Couturier J, Saster-Garau X, Schneider-Manoury S, Labib A, Orth G. Integration of papillomavirus near myc genes in genital carcinomas and its consequences for proto-onocogene expression. J Virol 1991;65:4534-8.
29. Hughes RG, Neill WA, Norval M. Papillomavirus and c-myc antigen expression in normal and neoplastic cervical epithelium. J Clin Pathol 1989;42:46-51.
30. Polacarz SV, Darne J, Sheridan EG, Ginsberg R, Sharp F. Endocervical carcinoma and precursor lesions: c-myc expression and the demonstration of field changes. J Clin Pathol 1991;44:896-9.